|

Antiandrogen Therapy Clinical Trials

4 actively recruiting trials across 4 locations

Also known as: ADT, Androgen Deprivation Therapy, Androgen Deprivation Therapy (ADT), Anti-androgen Therapy, Anti-androgen Treatment +3 more

Pipeline

Phase 2: 3Phase 3: 1

Top Sponsors

  • Northwestern University1
  • Mayo Clinic1
  • M.D. Anderson Cancer Center1
  • City of Hope Medical Center1

Indications

  • Cancer4
  • Stage IIC Prostate Cancer AJCC v82
  • Prostate Carcinoma2
  • Stage III Prostate Cancer AJCC v82
  • Heart Disease1

Scottsdale, Arizona1 trial

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Mayo Clinic in Arizona

Phase 3

Duarte, California1 trial

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

City of Hope Medical Center

Phase 2

Chicago, Illinois1 trial

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Northwestern University

Phase 2

Houston, Texas1 trial

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.